Complete radiographic response to immunotherapy in a patient with metastatic anaplastic thyroid cancer – a case report and review of the literature - Summary - MDSpire

Complete radiographic response to immunotherapy in a patient with metastatic anaplastic thyroid cancer – a case report and review of the literature

  • By

  • Monika Mierzejewska

  • Lin Akily

  • William Karlsen

  • Jacek Teodorczyk

  • Bartłomiej Tomasik

  • Jacek Rutkowski

  • Piotr Wiśniewski

  • Maciej Śledziński

  • Karolina Markiet

  • Jolanta Szade

  • Renata Zaucha

  • Wojciech Cytawa

  • June 2, 2026

  • 0 min

Share

Objective:

To present the case of a patient with recurrent metastatic anaplastic thyroid cancer (ATC) treated with immune checkpoint inhibitor (ICI) therapy after exhausting standard treatment options.

Key Findings:
  • The patient achieved prolonged progression-free survival of 12 months and overall survival of 18 months.
  • Nivolumab treatment resulted in a complete radiographic response of pulmonary metastases.
  • The patient experienced grade 3 colitis and a Clostridium difficile infection as side effects.
Interpretation:

Limitations:
  • The findings are based on a single case report.
Conclusion:

Original Source(s)

Complete radiographic response to immunotherapy in a patient with metastatic anaplastic thyroid cancer – a case report and review of the literature

  • by Monika Mierzejewska, Lin Akily, William Karlsen, Jacek Teodorczyk, Bartłomiej Tomasik, Jacek Rutkowski, Piotr Wiśniewski, Maciej Śledziński, Karolina Markiet, Jolanta Szade, Renata Zaucha, Wojciech Cytawa

  • June 2, 2026

Related Content

Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for Cancer

Sustained complete response to TMEp-CI-M platform in refractory small-cell lung cancer with brainstem metastasis: a case report with over 20 months of disease-free survival

Signals of inequity in the care pathway: rural lab diagnosis, systemic therapy delays, and RAS mutation differences in metastatic colorectal cancer